In silico, in vitro and cellular analysis with a kinome-wide inhibitor panel correlates cellular LRRK2 dephosphorylation to inhibitor activity on LRRK2
Leucine-rich repeat kinase 2 (LRRK2) is a complex, multidomain protein which is considered a valuable target for potential disease-modifying therapeutic strategies for Parkinson’s disease. In mammalian cells and brain, LRRK2 is phosphorylated and treatment of cells with inhibitors of LRRK2 kinase ac...
Main Authors: | Renee eVancraenenbroeck, Joren eDe Raeymaecker, Evy eLobbestael, Fangye eGao, Marc eDe Maeyer, Arnout eVoet, Veerle eBaekelandt, Jean-Marc eTaymans |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-06-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnmol.2014.00051/full |
Similar Items
-
Phosphatases of α-synuclein, LRRK2 and tau: important players in the phosphorylation-dependent pathology of Parkinsonism
by: Jean-Marc eTaymans, et al.
Published: (2014-11-01) -
LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.
by: Jean-Marc Taymans, et al.
Published: (2011-01-01) -
Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes
by: Kushal Sejwal, et al.
Published: (2017-08-01) -
Regulation and targeting of enzymes mediating Parkinson’s disease pathogenesis: focus on Parkinson’s disease kinases, GTPases and ATPases
by: Jean-Marc eTaymans, et al.
Published: (2014-07-01) -
Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation
by: Diego Cabezudo, et al.
Published: (2020-04-01)